Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-004476

CVP, Chief Financial Officer sold 13,000 shares at an average $80.04 ($1,040,544)

  • CVP, Chief Financial Officer acquired 13,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2026-04-09 Option exercise 10b5-1 +13,000 $59.26 $770,337 52,699 D: show line 1 in the form
Ullem Scott B. CVP, Chief Financial Officer 2026-04-09 Sale 10b5-1 −4,676 $80.50 $376,401 48,023 D: show line 2 in the form
Ullem Scott B. CVP, Chief Financial Officer 2026-04-09 Sale 10b5-1 −8,324 $79.79 $664,144 39,699 D: show line 3 in the form
Open-market sales · 13,000 sh · avg $80.04 · $1,040,544

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2026-04-09 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −13,000 13,000 D: show line 4 in the form
Loading xslF345X06/doc4.xml…